penciclovir  - Drug Details
📊 Estimates penciclovir  Dialyzability By Different_Modalities

penciclovir 

Complete Drug Information

Drug Name
penciclovir 
Trade Names
Denavir
Pregnancy Category
AU: B1
Bioavailability
1.5% (oral), negligible (topical)
Routes of Administration
Topical
Protein Binding
<20%%
Metabolism
Viral thymidine kinase
Elimination
2.2–2.3 hours
Excretion
Kidney
Formula
C10H15N5O3
Molar Mass
253.262
Melting Point
275 to 277 °C
Volume of Distribution
C10H15N5O3

🤰 Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.